www.fdanews.com/articles/182229-baxter-wins-fda-clearance-of-clindamycin-injection
Baxter Wins FDA Clearance of Clindamycin Injection
June 15, 2017
The FDA has cleared Baxter’s ready-to-use clindamycin injection in saline in three prescribed formulations (300mg/50mL, 600mg/50mL, 900mg/50mL).
Clindamycin injection in saline provides an alternative to administer to patients for whom the use of dextrose is contraindicated or undesirable.
Baxter’s ready-to-use clindamycin injection in saline is now available in the U.S.